Event Date/Time: Mar 21, 2005
End Date/Time: Mar 22, 2005
Glycomics, one of the newest additions to the ‘omics’ family has recently experienced a huge surge of interest in the biopharmaceutical industry. The recognition of the important role glycosylation is playing in biological functions has led to a significant increase in biopharmaceutical companies who focus their research on carbohydrate - based drug development. Advanced technologies in analysis and synthesis result in better data about glycan structures, binding specifities and also on carbohydrate related genes. In addition, the number of carbohydrate related human diseases discovered is steadily increasing. New drugs are being developed in areas such as cancer treatment, angiogenesis, and vaccines. This conference presents the newest technologies and top experts will address current challenges in Glycomics research as well as highlight newly developing applications for carbohydrates and drug development.